Samir Abdelmagid, Ph.D.
Affiliations: | 2006 | Temple University, Philadelphia, PA, United States |
Area:
Cell BiologyGoogle:
"Samir Abdelmagid"Parents
Sign in to add mentor| Fayez F. Safadi | grad student | 2006 | Temple University | |
| (Characterization and regulation of osteoactivin expression in osteoblasts.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sondag GR, Mbimba TS, Moussa FM, et al. (2016) Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signaling. Experimental & Molecular Medicine. 48: e257 |
| Zhou X, Moussa FM, Mankoci S, et al. (2016) Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation. Acta Biomaterialia |
| Frara N, Abdelmagid SM, Tytell M, et al. (2016) Growth and repair factors, osteoactivin, matrix metalloproteinase and heat shock protein 72, increase with resolution of inflammation in musculotendinous tissues in a rat model of repetitive grasping. Bmc Musculoskeletal Disorders. 17: 34 |
| Frara N, Abdelmagid SM, Sondag GR, et al. (2016) Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo. Journal of Cellular Physiology. 231: 72-83 |
| Abdelmagid SM, Sondag GR, Moussa FM, et al. (2015) Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function. The Journal of Biological Chemistry. 290: 20128-46 |
| Abdelmagid SM, Barbe MF, Safadi FF. (2015) Role of inflammation in the aging bones. Life Sciences. 123: 25-34 |
| Abdelmagid SM, Sondag GR, Moussa FM, et al. (2015) Mutation in osteoactivin promotes receptor activator of NFκB ligand (RANKL)-mediated osteoclast differentiation and survival but inhibits osteoclast function Journal of Biological Chemistry. 290: 20128-20146 |
| Geldenhuys WJ, Abdelmagid SM, Gallegos PJ, et al. (2014) Parkinson's disease biomarker: a patent evaluation of WO2013153386. Expert Opinion On Therapeutic Patents. 24: 947-51 |
| Abdelmagid SM, Belcher JY, Moussa FM, et al. (2014) Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro. The American Journal of Pathology. 184: 697-713 |
| Moussa FM, Hisijara IA, Sondag GR, et al. (2014) Osteoactivin promotes osteoblast adhesion through HSPG and αvβ1 integrin. Journal of Cellular Biochemistry. 115: 1243-53 |